Literature DB >> 2228316

Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis.

A Raz1, D G Zhu, V Hogan, N Shah, T Raz, R Karkash, G Pazerini, P Carmi.   

Abstract

The endogenous Mr 34,000 galactoside-binding lectin (L-34) is found at elevated levels in a wide variety of neoplastic cells and correlative evidence suggests that it is involved in tumor metastasis in vivo and in transformation in vitro. We demonstrate here that introduction of recombinant L-34 into tumorigenic, weakly metastatic UV-2237-cl-15 fibrosarcoma cells results in an increased incidence of experimental lung metastases in syngeneic and nude mice. Transfection of normal BALB/c-A31 cloned fibroblasts with functional L-34 results in acquisition of anchorage-independent growth and in morphological transformation in vitro but not in tumorigenicity in vivo. These results provide direct evidence that the cellular expression of L-34 is associated with some aspects of transformation and with metastasis, but not with tumorigenicity per se.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228316     DOI: 10.1002/ijc.2910460520

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  34 in total

1.  Expression of galectin-3 modulates T-cell growth and apoptosis.

Authors:  R Y Yang; D K Hsu; F T Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family.

Authors:  Z Z Su; J Lin; R Shen; P E Fisher; N I Goldstein; P B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses.

Authors:  D K Hsu; R Y Yang; Z Pan; L Yu; D R Salomon; W P Fung-Leung; F T Liu
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Decreased galectin-3 expression during the progression of cervical neoplasia.

Authors:  Jeong-Won Lee; Sang Yong Song; Jung-Joo Choi; Chel Hun Choi; Tae-Joong Kim; Jhingook Kim; Je-Ho Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-21       Impact factor: 4.553

5.  The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma.

Authors:  Ling Xie; Wen-Kai Ni; Xu-Dong Chen; Ming-Bing Xiao; Bu-You Chen; Song He; Cui-Hua Lu; Xiao-Yan Li; Feng Jiang; Run-Zhou Ni
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-25       Impact factor: 4.553

6.  Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma.

Authors:  M M Lotz; C W Andrews; C A Korzelius; E C Lee; G D Steele; A Clarke; A M Mercurio
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

7.  Regulation of prostate cancer progression by galectin-3.

Authors:  Yi Wang; Pratima Nangia-Makker; Larry Tait; Vitaly Balan; Victor Hogan; Kenneth J Pienta; Avraham Raz
Journal:  Am J Pathol       Date:  2009-03-12       Impact factor: 4.307

Review 8.  The emerging role of galectins in high-fatality cancers.

Authors:  Cherylane Dubé-Delarosbil; Yves St-Pierre
Journal:  Cell Mol Life Sci       Date:  2017-11-08       Impact factor: 9.261

9.  Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions.

Authors:  H Inohara; A Raz
Journal:  Glycoconj J       Date:  1994-12       Impact factor: 2.916

10.  Expression of galectin-3 correlates with apoptosis in pituitary adenoma cells.

Authors:  Chui-Xue Huang; Yong-Hong Hou; Yun-Sheng Liu
Journal:  Neurosci Bull       Date:  2008-02       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.